Role of Sphingolipids in Pulmonary Edema

In this mono-center prospective study, the impact of changes in the sphingolipid metabolism in patients with pulmonary edema will be investigated.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pulmonary Edema Lung Diseases Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical Clinic I, University Hospital Aachen

Aachen, North Rhine-Westphalia, 52074, Germany

About this study

There will be three groups of patients:

hydrostatic pulmonary edema
toxic pulmonary edema
not ventilated patients without any pulmonary edema

Samples of a routine bronchoalveolar lavage and EDTA-blood will be analysed in respect of sphingolipids, ceramide, sphingomyelin-phosphodiesterase and several cytokines.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

above the age of 18

Exclusion criteria

taking steroids

Sponsors and collaborators

Lead sponsor

RWTH Aachen University

Other

Registry information

Acronym: 09-045

Important dates

Study start: 2010
Primary completion: 2012
Study completion: 2013
First posted: Jul 14, 2010
Registry last updated: Sep 23, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed